ELAYNE FAUCETT-MAPLES: Open Payments
NPI 1659901239 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Ardelyx, Inc. | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: ENTYVIO, IBSRELA, TREMFYA.
Industry payments across CA — which companies pay providers there.
